/EMGE

EMGE Stock - Emergent Health Corp

Q: What is the analyst price target for EMGE?

Analyst price target information is not currently available for EMGE.

Q: What is EMGE's market cap?

Market capitalization information is not currently available for EMGE.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

SELL

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EMGE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta7.54

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$1.64M	$574,613	$119,567	$167,191	$183,120
Gross Profit	$1.04M	$127,639	$59,477	$121,421	$128,654
Gross Margin	63.5%	22.2%	49.7%	72.6%	70.3%
Operating Income	$-1,407,830	$-1,756,060	$-199,570	$-79,740	$-58,740
Net Income	$-1,628,073	$-2,107,450	$-288,764	$-79,125	$-67,498
Net Margin	-99.6%	-366.8%	-241.5%	-47.3%	-36.9%
EPS	$-0.00	$-0.01	$-0.01	$-0.00	$-0.00

Company Overview

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.

Visit Website

Frequently Asked Questions about EMGE

What is EMGE's current stock price?

Emergent Health Corp (EMGE) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for EMGE?

No analyst price targets are currently available for this stock.

What sector is Emergent Health Corp in?

Emergent Health Corp operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is EMGE's market cap?

Emergent Health Corp has a market capitalization of $0.00 billion, making it a small-cap company.

Does EMGE pay dividends?

No, Emergent Health Corp does not currently pay a dividend to shareholders.